598
Views
73
CrossRef citations to date
0
Altmetric
Original Research

Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol

, , , &
Pages 117-128 | Published online: 05 Jan 2016

References

  • FarnsworthNRAkereleOBingelASSoejartoDDGuoZMedicinal plants in therapyBull WHO1985639659813879679
  • AmriAChaumeilJCSfarSCharrueauCAdministration of resveratrol: What formulation solutions to bioavailability limitations?J Control Release201215818219321978644
  • AnsariKAVaviaPRTrottaFCavalliRCyclodextrin-based nanosponges for delivery of Resveratrol: In vitro characterisation, stability, cytotoxicity and permeation studyAAPS Pharm Sci Tech2011121279286
  • DasSDasDKResveratrol: a therapeutic promise for cardiovascular diseasesRecent Pat Cardiovasc Drug Discov2007213313818221111
  • HungLMSuMJChenJKResveratrol protects myocardial ischemia–reperfusion injury through both NO-dependent and NO-independent mechanismsFree Radic Biol Med20043677478114990356
  • BaurJASinclairDATherapeutic potential of resveratrol: the in vivo evidenceNat Rev Drug Discov20065649350616732220
  • SzkudelskiTSzkudelskaKAnti-diabetic effects of resveratrolAnn NY Acad Sci20111215343921261639
  • HausenblasHASchouldaJASmoligaJMResveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus – systematic review and meta-analysisMol Nutr Food Res201559114715925138371
  • BoocockDJFaustGESPatelKRPhase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agentCancer Epidemiol Biomarkers Prev20071661246125217548692
  • KristlJTeskacKCaddeoCAbramovićZSentjurcMImprovement of cellular stress response on Resveratrol in liposomesEur J Pharm Biopharm200973225325919527785
  • AmidonGLLennernäsHShahVPCrisonJRA theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailabilityPharm Res19951234134207617530
  • López-NicolásJMNúñez-DelicadoEPérez-LópezAJBarrachinaACCuadra-CrespoPDetermination of stoichiometric coefficients and apparent formation constants for β-cyclodextrin complexes of trans-resveratrol using reversed-phase liquid chromatographyJ Chromatogr A20061135215816517083948
  • GokceEHKorkmazEDelleraESandriGBonferoniMCOzerOResveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applicationsInt J Nanomed2012718411850
  • AtanackovićMTGojković-BukaricaLCCvejićJMImproving the low solubility of resveratrolPresented at: 18th Scientific Symposium of the Austrian Pharmacological Society (APHAR) joint meeting with the Croatian, Serbian and Slovenian Pharmacological SocietiesSeptember 20–21, 2012Graz, Austria
  • BhattacharyyaABajpaiMDevelopment and evaluation of a self-emulsifying drug delivery system of amphotericin BAsian J Pharm201262124129
  • SapraKSapraASinghSKKakkarSSelf emulsifying drug delivery system: A tool in solubility enhancement of poorly soluble drugsIndo Global J Pharm Sci201223313332
  • CharmanSACharmanWNRoggeMCWilsonTDDutkoFJPoutonCWSelf emulsifying drug delivery systems: formulation and biopharmaceutical evaluation of an investigational lipophilic compoundPharm Res19929187931589415
  • BalakrishnanPLeeBOhDHEnhanced oral bioavailability of dexibuprofen by a novel solid Self-emulsifying drug delivery system (SEDDS)Eur J Pharm Biopharm200972353954519298857
  • MeiXEtzlerFMWangZUse of texture analysis to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsulesInt J Pharm2006324212813516844327
  • HarshalMTanvirSDheerajBRajendraWDesign and development of solid self-micro-emulsifying drug delivery system (SEDDS) of fenofibrateInt J Pharm Pharm Sci201134163166
  • ShahNHCarvajalMTPatelCIInfeldMHMalickAWSelf-emulsifying drug delivery systems (SEDDS) with polyglycolysed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugsInt J Pharm199410611523
  • Society of ToxicologyGuiding Principles in the Use of Animals in ToxicologyReston, VASociety of Toxicology2008 Available from: http://www.toxicology.org/AI/FA/guidingprinciples.pdfAccessed August 6, 2013
  • SchmatzRMazzantiCMSpanevelloREctonucleotidase and acetylcholinesterase activities in synaptosomes from the cerebral cortex of streptozotocin-induced diabetic rats and treated with resveratrolBrain Res Bull200980637137619723569
  • LeeESShinMOYoonSMoonJOResveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in ratsArch Pharm Res201033692593220607498
  • FriedewaldWTLevyRIFredricksonDSEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeClin Chem19721864995024337382
  • BiswalSSahooJMurthyPNGiradkarRPAvariJGEnhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000AAPS Pharm Sci Tech200892563570
  • KallakuntaVRBandariSJukantiRVeerareddyPROral self emulsifying powder of lercanidipine hydrochloride: Formulation and evaluationPowd Tech2012221375382
  • PatelARVaviaPRPreparation and in vivo evaluation of SMEDDS (self microemulsifying drug delivery system) containing fenofibrateAAPS J200793E344E35218170981
  • KassemAAMarzoukMAAmmarAAElosailyGHPreparation and in vitro evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) containing clotrimazoleDrug Discov Ther20104537337922491242
  • ReissHEntropy-induced dispersion of bulk liquidsJ Colloids Interface Sci19755316170
  • DerleDVSagarBSHPimpaleSMicroemulsion as a vehicle for transdermal permeation of nimesulideInd J Pharm Sci2006685622625
  • RaoSVRShaoJSelf-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs. I. Formulation developmentInt J Pharm20083621–22918650038
  • BhikshapathiDMadhukarPKumarBDKumarGAFormulation and characterization of pioglitazone HCl self emulsifying drug delivery systemDer Pharmacia Let201352292305
  • GursoyRNBenitaSSelf-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugsBiomed Pharmacother200458317318215082340
  • KhanFIslamSRoniMAJalilRSystematic development of self-emulsifying drug delivery systems of atorvastatin with improved bioavailabilityPotential Sci Pharm20128041027104323264948
  • SureshPKSharmaSFormulation and in-vitro characterization of self-nanoemulsifying drug delivery system of cinnarizineInt J Compr Pharm20119816
  • BurtisCAAshwoodERCarbohydratesSaundersWBTietz Textbook of Clinical ChemistryPhiladelphia, Pa, USA1999750808
  • KallakuntaVREedaraBBJukantiRAjmeeraRKSuresh BandariSA Gelucire 44/14 and labrasol based solid self emulsifying drug delivery system: formulation and evaluationJ Pharm Invest201343185196
  • TuranBTuncayEVassortGResveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studiesJ Bioenerg Biomembr201244228129622437738
  • SoufiFGVardyaniMSheervalilouRMohammadiMSomiMHLong-term treatment with resveratrol attenuates oxidative stress pro-inflammatory mediators and apoptosis in streptozotocin-nicotinamide-induced diabetic ratsGen Physiol Biophys201231443143823255670
  • MiuraDMiuraYYagasakiKHypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing ratsLife Sci200373111393140012850500
  • PenumathsaSVThirunavukkarasuMZhanLResveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardiumJ Cell Mol Med2008122350236118266981
  • BrasnyoPMolnarGAMohasMResveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patientsBr J Nutr2011106338338921385509
  • CrandallJPOramVTrandafirescuGPilot study of resveratrol in older adults with impaired glucose toleranceJ Gerontol A Biol Sci Med Sci201267121307131222219517
  • PalsamyPSubramanianSAmeliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic b-cell dysfunction in streptozotocin-nicotinamide-induced diabetic ratsJ Cell Physiol2010224242343220333650
  • RiveraLMoronRZarzueloAGalisteoMLong-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker ratsBiochem Pharmacol20097761053106319100718
  • DoGMKwonEYKimHJJeonSMHaTYParkTLong-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient miceBiochem Biophys Res Commun20083741555918611391
  • KimSJinYChoiYParkTResveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in miceBiochem Pharmacol2011811343135121439945